

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | L-phenylalanine catabolic process (GO:0006559) | 7.08261656 |
| 2 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.08261656 |
| 3 | epoxygenase P450 pathway (GO:0019373) | 6.88907082 |
| 4 | L-phenylalanine metabolic process (GO:0006558) | 6.80237723 |
| 5 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.80237723 |
| 6 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 6.58622274 |
| 7 | aromatic amino acid family catabolic process (GO:0009074) | 6.29950797 |
| 8 | omega-hydroxylase P450 pathway (GO:0097267) | 6.11025561 |
| 9 | indole-containing compound catabolic process (GO:0042436) | 5.60230787 |
| 10 | indolalkylamine catabolic process (GO:0046218) | 5.60230787 |
| 11 | tryptophan catabolic process (GO:0006569) | 5.60230787 |
| 12 | high-density lipoprotein particle remodeling (GO:0034375) | 5.53398814 |
| 13 | alpha-linolenic acid metabolic process (GO:0036109) | 5.46422169 |
| 14 | glyoxylate metabolic process (GO:0046487) | 5.44325054 |
| 15 | kynurenine metabolic process (GO:0070189) | 5.43195359 |
| 16 | urea metabolic process (GO:0019627) | 5.40664255 |
| 17 | urea cycle (GO:0000050) | 5.40664255 |
| 18 | cysteine metabolic process (GO:0006534) | 5.37339945 |
| 19 | tryptophan metabolic process (GO:0006568) | 5.31435108 |
| 20 | regulation of cholesterol esterification (GO:0010872) | 5.24852541 |
| 21 | bile acid biosynthetic process (GO:0006699) | 5.23233023 |
| 22 | sulfur amino acid catabolic process (GO:0000098) | 4.99861057 |
| 23 | phospholipid efflux (GO:0033700) | 4.96953065 |
| 24 | nitrogen cycle metabolic process (GO:0071941) | 4.96409628 |
| 25 | reverse cholesterol transport (GO:0043691) | 4.95471021 |
| 26 | lysine metabolic process (GO:0006553) | 4.91653309 |
| 27 | lysine catabolic process (GO:0006554) | 4.91653309 |
| 28 | regulation of triglyceride catabolic process (GO:0010896) | 4.89464045 |
| 29 | negative regulation of fibrinolysis (GO:0051918) | 4.89305651 |
| 30 | negative regulation of cholesterol transport (GO:0032375) | 4.88953959 |
| 31 | negative regulation of sterol transport (GO:0032372) | 4.88953959 |
| 32 | serine family amino acid catabolic process (GO:0009071) | 4.88931707 |
| 33 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.81748327 |
| 34 | protein-lipid complex remodeling (GO:0034368) | 4.79275334 |
| 35 | macromolecular complex remodeling (GO:0034367) | 4.79275334 |
| 36 | plasma lipoprotein particle remodeling (GO:0034369) | 4.79275334 |
| 37 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.76211632 |
| 38 | protein carboxylation (GO:0018214) | 4.76211632 |
| 39 | homocysteine metabolic process (GO:0050667) | 4.73190754 |
| 40 | bile acid metabolic process (GO:0008206) | 4.71369770 |
| 41 | regulation of fibrinolysis (GO:0051917) | 4.65440079 |
| 42 | amino-acid betaine metabolic process (GO:0006577) | 4.63289320 |
| 43 | aromatic amino acid family metabolic process (GO:0009072) | 4.58148087 |
| 44 | intestinal cholesterol absorption (GO:0030299) | 4.56597707 |
| 45 | ethanol metabolic process (GO:0006067) | 4.54814431 |
| 46 | triglyceride homeostasis (GO:0070328) | 4.52867208 |
| 47 | acylglycerol homeostasis (GO:0055090) | 4.52867208 |
| 48 | cholesterol efflux (GO:0033344) | 4.49670033 |
| 49 | fibrinolysis (GO:0042730) | 4.49107097 |
| 50 | cellular ketone body metabolic process (GO:0046950) | 4.46564855 |
| 51 | plasma lipoprotein particle assembly (GO:0034377) | 4.39637259 |
| 52 | tyrosine metabolic process (GO:0006570) | 4.36465421 |
| 53 | alpha-amino acid catabolic process (GO:1901606) | 4.36096667 |
| 54 | bile acid and bile salt transport (GO:0015721) | 4.34443801 |
| 55 | regulation of protein activation cascade (GO:2000257) | 4.33774460 |
| 56 | plasma lipoprotein particle clearance (GO:0034381) | 4.33418539 |
| 57 | complement activation, alternative pathway (GO:0006957) | 4.21483818 |
| 58 | oxidative demethylation (GO:0070989) | 4.21195828 |
| 59 | drug transmembrane transport (GO:0006855) | 4.15386265 |
| 60 | glutamate metabolic process (GO:0006536) | 4.14151641 |
| 61 | positive regulation of lipoprotein lipase activity (GO:0051006) | 4.10714042 |
| 62 | positive regulation of triglyceride lipase activity (GO:0061365) | 4.10714042 |
| 63 | cellular amino acid catabolic process (GO:0009063) | 4.05960999 |
| 64 | cellular glucuronidation (GO:0052695) | 4.05540780 |
| 65 | very-low-density lipoprotein particle assembly (GO:0034379) | 4.04655930 |
| 66 | urate metabolic process (GO:0046415) | 4.04188835 |
| 67 | serine family amino acid metabolic process (GO:0009069) | 4.01147940 |
| 68 | flavonoid metabolic process (GO:0009812) | 4.00971653 |
| 69 | short-chain fatty acid metabolic process (GO:0046459) | 4.00545441 |
| 70 | protein-lipid complex assembly (GO:0065005) | 4.00494444 |
| 71 | indolalkylamine metabolic process (GO:0006586) | 3.99254899 |
| 72 | regulation of bile acid biosynthetic process (GO:0070857) | 3.99105579 |
| 73 | regulation of complement activation (GO:0030449) | 3.98418605 |
| 74 | cellular modified amino acid catabolic process (GO:0042219) | 3.96757663 |
| 75 | benzene-containing compound metabolic process (GO:0042537) | 3.95084489 |
| 76 | cholesterol homeostasis (GO:0042632) | 3.94939530 |
| 77 | fat-soluble vitamin biosynthetic process (GO:0042362) | 3.93593297 |
| 78 | phenylpropanoid metabolic process (GO:0009698) | 3.93077991 |
| 79 | S-adenosylmethionine metabolic process (GO:0046500) | 3.91919682 |
| 80 | glycine metabolic process (GO:0006544) | 3.91356330 |
| 81 | sterol homeostasis (GO:0055092) | 3.90999413 |
| 82 | regulation of cholesterol homeostasis (GO:2000188) | 3.89669581 |
| 83 | lipoprotein metabolic process (GO:0042157) | 3.89399366 |
| 84 | ketone body metabolic process (GO:1902224) | 3.85837196 |
| 85 | intestinal absorption (GO:0050892) | 3.84850478 |
| 86 | exogenous drug catabolic process (GO:0042738) | 3.84691545 |
| 87 | * drug catabolic process (GO:0042737) | 3.84691545 |
| 88 | ethanol oxidation (GO:0006069) | 3.84492952 |
| 89 | amine catabolic process (GO:0009310) | 3.83735159 |
| 90 | cellular biogenic amine catabolic process (GO:0042402) | 3.83735159 |
| 91 | phospholipid homeostasis (GO:0055091) | 3.83379566 |
| 92 | hormone catabolic process (GO:0042447) | 3.83202193 |
| 93 | serine family amino acid biosynthetic process (GO:0009070) | 3.81733435 |
| 94 | positive regulation of lipid catabolic process (GO:0050996) | 3.81417375 |
| 95 | low-density lipoprotein particle remodeling (GO:0034374) | 3.81309911 |
| 96 | arginine metabolic process (GO:0006525) | 3.78752441 |
| 97 | complement activation (GO:0006956) | 3.77830413 |
| 98 | blood coagulation, intrinsic pathway (GO:0007597) | 3.75964519 |
| 99 | protein activation cascade (GO:0072376) | 3.74633637 |
| 100 | coenzyme catabolic process (GO:0009109) | 3.74404746 |
| 101 | plasma lipoprotein particle organization (GO:0071827) | 3.73064917 |
| 102 | imidazole-containing compound metabolic process (GO:0052803) | 3.72362444 |
| 103 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 3.71627864 |
| 104 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.70865546 |
| 105 | negative regulation of hemostasis (GO:1900047) | 3.67362902 |
| 106 | negative regulation of blood coagulation (GO:0030195) | 3.67362902 |
| 107 | negative regulation of protein activation cascade (GO:2000258) | 3.66453831 |
| 108 | glucuronate metabolic process (GO:0019585) | 3.65326064 |
| 109 | uronic acid metabolic process (GO:0006063) | 3.65326064 |
| 110 | organic acid catabolic process (GO:0016054) | 3.64594921 |
| 111 | carboxylic acid catabolic process (GO:0046395) | 3.64594921 |
| 112 | xenobiotic catabolic process (GO:0042178) | 3.61731794 |
| 113 | aldehyde catabolic process (GO:0046185) | 3.61399212 |
| 114 | complement activation, classical pathway (GO:0006958) | 3.61086007 |
| 115 | * drug metabolic process (GO:0017144) | 3.58261191 |
| 116 | primary alcohol catabolic process (GO:0034310) | 3.57888207 |
| 117 | acetyl-CoA metabolic process (GO:0006084) | 3.57464218 |
| 118 | aspartate family amino acid catabolic process (GO:0009068) | 3.56768047 |
| 119 | drug transport (GO:0015893) | 3.56482903 |
| 120 | regulation of humoral immune response (GO:0002920) | 3.50459708 |
| 121 | heme transport (GO:0015886) | 3.49900856 |
| 122 | acute-phase response (GO:0006953) | 3.47452920 |
| 123 | negative regulation of coagulation (GO:0050819) | 3.45697911 |
| 124 | negative regulation of wound healing (GO:0061045) | 3.33730688 |
| 125 | negative regulation of complement activation (GO:0045916) | 3.32260693 |
| 126 | alkaloid metabolic process (GO:0009820) | 3.31726023 |
| 127 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 3.15506382 |
| 128 | L-ascorbic acid metabolic process (GO:0019852) | 3.14622292 |
| 129 | xenobiotic metabolic process (GO:0006805) | 3.06817744 |
| 130 | positive regulation of blood coagulation (GO:0030194) | 3.05928123 |
| 131 | positive regulation of hemostasis (GO:1900048) | 3.05928123 |
| 132 | glycosphingolipid catabolic process (GO:0046479) | 3.05825882 |
| 133 | regulation of plasminogen activation (GO:0010755) | 3.05819460 |
| 134 | positive regulation of coagulation (GO:0050820) | 3.05310045 |
| 135 | negative regulation of lipase activity (GO:0060192) | 3.01501148 |
| 136 | glutamine family amino acid biosynthetic process (GO:0009084) | 2.96467586 |
| 137 | regulation of sterol transport (GO:0032371) | 2.96113911 |
| 138 | regulation of cholesterol transport (GO:0032374) | 2.96113911 |
| 139 | negative regulation of humoral immune response (GO:0002921) | 2.91852076 |
| 140 | proline metabolic process (GO:0006560) | 2.89520198 |
| 141 | primary alcohol metabolic process (GO:0034308) | 2.89149266 |
| 142 | monocarboxylic acid catabolic process (GO:0072329) | 2.89026521 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 8.09449325 |
| 2 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 6.97281146 |
| 3 | * EGR1_23403033_ChIP-Seq_LIVER_Mouse | 6.41865149 |
| 4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.39620842 |
| 5 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.80104306 |
| 6 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.73250905 |
| 7 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.63900518 |
| 8 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.88042034 |
| 9 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.69208540 |
| 10 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.83773268 |
| 11 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.35052884 |
| 12 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 11.2359775 |
| 13 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.99577534 |
| 14 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.98967591 |
| 15 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.96370823 |
| 16 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.95709274 |
| 17 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.87737742 |
| 18 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.79827898 |
| 19 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.74798974 |
| 20 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.73419911 |
| 21 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.69408447 |
| 22 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.63244791 |
| 23 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.58381167 |
| 24 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.57934302 |
| 25 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.51134887 |
| 26 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.43862340 |
| 27 | GATA1_22025678_ChIP-Seq_K562_Human | 1.41047823 |
| 28 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.40344732 |
| 29 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.39542710 |
| 30 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.36672264 |
| 31 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.28622128 |
| 32 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.27249678 |
| 33 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.27231200 |
| 34 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.27121770 |
| 35 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.21518896 |
| 36 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.20443848 |
| 37 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.20132649 |
| 38 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.19254681 |
| 39 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.17803437 |
| 40 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.14990441 |
| 41 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.11139517 |
| 42 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.09100700 |
| 43 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.05175425 |
| 44 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.04997250 |
| 45 | * GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 1.03132429 |
| 46 | HNFA_21074721_ChIP-Seq_CACO-2_Human | 1.02857905 |
| 47 | * CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 1.02837763 |
| 48 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.01973029 |
| 49 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.99486603 |
| 50 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.98130499 |
| 51 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.97463766 |
| 52 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 0.97143309 |
| 53 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.96503236 |
| 54 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.95621551 |
| 55 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.94995024 |
| 56 | AR_21909140_ChIP-Seq_LNCAP_Human | 0.94749487 |
| 57 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 0.93396896 |
| 58 | * GATA6_21074721_ChIP-Seq_CACO-2_Human | 0.92952993 |
| 59 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.92871580 |
| 60 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.91298700 |
| 61 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.90438193 |
| 62 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 0.90394358 |
| 63 | * PHF8_20622853_ChIP-Seq_HELA_Human | 0.89391723 |
| 64 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.88953285 |
| 65 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.88041570 |
| 66 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.87968001 |
| 67 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.86918062 |
| 68 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.86735011 |
| 69 | GATA3_26560356_Chip-Seq_TH2_Human | 0.86053084 |
| 70 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.84041343 |
| 71 | * SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.83728424 |
| 72 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.83379455 |
| 73 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.82333975 |
| 74 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.82028881 |
| 75 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.81574605 |
| 76 | MYB_26560356_Chip-Seq_TH2_Human | 0.79901065 |
| 77 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.78104006 |
| 78 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.77396994 |
| 79 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.77031773 |
| 80 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.76857529 |
| 81 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.76122746 |
| 82 | * EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.76082055 |
| 83 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.76078556 |
| 84 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.74327469 |
| 85 | * ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.74136543 |
| 86 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.73887334 |
| 87 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.73829057 |
| 88 | MYB_26560356_Chip-Seq_TH1_Human | 0.72708805 |
| 89 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.72208481 |
| 90 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.72167699 |
| 91 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.71958977 |
| 92 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.71128826 |
| 93 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.69953028 |
| 94 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.69670275 |
| 95 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.69625170 |
| 96 | * CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.69417497 |
| 97 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.69350849 |
| 98 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.68303388 |
| 99 | NFYA_21822215_ChIP-Seq_K562_Human | 0.68238226 |
| 100 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.67966154 |
| 101 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.67718337 |
| 102 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.67014392 |
| 103 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.67014392 |
| 104 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.66173262 |
| 105 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.65813949 |
| 106 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.63123004 |
| 107 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.62835904 |
| 108 | * STAT1_17558387_ChIP-Seq_HELA_Human | 0.62768657 |
| 109 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.61084135 |
| 110 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.60967112 |
| 111 | * FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.59863406 |
| 112 | GATA2_19941826_ChIP-Seq_K562_Human | 0.59740152 |
| 113 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.58945885 |
| 114 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.57380565 |
| 115 | * FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.57192652 |
| 116 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.57129107 |
| 117 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.56897257 |
| 118 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.56151867 |
| 119 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.56012370 |
| 120 | GATA1_19941826_ChIP-Seq_K562_Human | 0.55610516 |
| 121 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.54785938 |
| 122 | AR_20517297_ChIP-Seq_VCAP_Human | 0.54691766 |
| 123 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.54003802 |
| 124 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.53698915 |
| 125 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 0.53683542 |
| 126 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.53136851 |
| 127 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.52924313 |
| 128 | CBP_21632823_ChIP-Seq_H3396_Human | 0.52857972 |
| 129 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.51598542 |
| 130 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.51533734 |
| 131 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.50123988 |
| 132 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.48787035 |
| 133 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.48346827 |
| 134 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.47439431 |
| 135 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.46944730 |
| 136 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.46797086 |
| 137 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.45166190 |
| 138 | * CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.44797239 |
| 139 | * PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.42598455 |
| 140 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.41595864 |
| 141 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.40862251 |
| 142 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.40632772 |
| 143 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.40553985 |
| 144 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.40396555 |
| 145 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.40112809 |
| 146 | SPI1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.39622099 |
| 147 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.39012995 |
| 148 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.38551539 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005360_urolithiasis | 8.37378436 |
| 2 | MP0002139_abnormal_hepatobiliary_system | 8.10615097 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 5.99527412 |
| 4 | MP0005365_abnormal_bile_salt | 5.73657089 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 5.08659881 |
| 6 | MP0003252_abnormal_bile_duct | 3.98855959 |
| 7 | MP0003806_abnormal_nucleotide_metabolis | 3.72735177 |
| 8 | MP0010329_abnormal_lipoprotein_level | 3.51298493 |
| 9 | MP0009840_abnormal_foam_cell | 3.47723491 |
| 10 | MP0001666_abnormal_nutrient_absorption | 3.11709090 |
| 11 | MP0005332_abnormal_amino_acid | 2.94768942 |
| 12 | MP0003195_calcinosis | 2.83757268 |
| 13 | MP0005083_abnormal_biliary_tract | 2.64644680 |
| 14 | MP0004019_abnormal_vitamin_homeostasis | 2.61593863 |
| 15 | MP0006054_spinal_hemorrhage | 2.35976018 |
| 16 | MP0003191_abnormal_cellular_cholesterol | 2.23031149 |
| 17 | MP0002138_abnormal_hepatobiliary_system | 2.08838370 |
| 18 | MP0000609_abnormal_liver_physiology | 2.04406395 |
| 19 | MP0002118_abnormal_lipid_homeostasis | 2.03644449 |
| 20 | MP0005319_abnormal_enzyme/_coenzyme | 1.70975346 |
| 21 | MP0006082_CNS_inflammation | 1.68122420 |
| 22 | MP0005451_abnormal_body_composition | 1.67889723 |
| 23 | MP0009785_altered_susceptibility_to | 1.66070438 |
| 24 | MP0009643_abnormal_urine_homeostasis | 1.62425015 |
| 25 | MP0003868_abnormal_feces_composition | 1.57084901 |
| 26 | MP0001764_abnormal_homeostasis | 1.53991017 |
| 27 | MP0009697_abnormal_copulation | 1.53027125 |
| 28 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.47195272 |
| 29 | MP0003303_peritoneal_inflammation | 1.45054336 |
| 30 | MP0003183_abnormal_peptide_metabolism | 1.43074848 |
| 31 | MP0001835_abnormal_antigen_presentation | 1.41547854 |
| 32 | MP0002148_abnormal_hypersensitivity_rea | 1.34341241 |
| 33 | MP0002132_abnormal_respiratory_system | 1.27759521 |
| 34 | MP0010155_abnormal_intestine_physiology | 1.21170654 |
| 35 | MP0005636_abnormal_mineral_homeostasis | 1.20348044 |
| 36 | MP0005084_abnormal_gallbladder_morpholo | 1.15627966 |
| 37 | MP0005025_abnormal_response_to | 1.15348480 |
| 38 | MP0004043_abnormal_pH_regulation | 1.13427855 |
| 39 | MP0005387_immune_system_phenotype | 1.12682778 |
| 40 | MP0001790_abnormal_immune_system | 1.12682778 |
| 41 | MP0003186_abnormal_redox_activity | 1.12213254 |
| 42 | MP0003705_abnormal_hypodermis_morpholog | 1.07913226 |
| 43 | MP0001845_abnormal_inflammatory_respons | 1.06998559 |
| 44 | MP0000598_abnormal_liver_morphology | 1.06726698 |
| 45 | MP0003656_abnormal_erythrocyte_physiolo | 1.05429989 |
| 46 | MP0000604_amyloidosis | 1.03446621 |
| 47 | MP0002419_abnormal_innate_immunity | 1.03251653 |
| 48 | MP0000685_abnormal_immune_system | 1.02397656 |
| 49 | MP0001853_heart_inflammation | 0.99596968 |
| 50 | MP0005000_abnormal_immune_tolerance | 0.98755120 |
| 51 | MP0005023_abnormal_wound_healing | 0.97859989 |
| 52 | MP0008004_abnormal_stomach_pH | 0.97572321 |
| 53 | MP0003011_delayed_dark_adaptation | 0.96441949 |
| 54 | MP0009764_decreased_sensitivity_to | 0.95742745 |
| 55 | MP0001800_abnormal_humoral_immune | 0.93609187 |
| 56 | MP0002254_reproductive_system_inflammat | 0.93431594 |
| 57 | MP0001756_abnormal_urination | 0.92698305 |
| 58 | MP0005408_hypopigmentation | 0.92284698 |
| 59 | MP0004264_abnormal_extraembryonic_tissu | 0.92164559 |
| 60 | MP0002876_abnormal_thyroid_physiology | 0.91399341 |
| 61 | MP0009642_abnormal_blood_homeostasis | 0.89293801 |
| 62 | MP0005647_abnormal_sex_gland | 0.84798894 |
| 63 | MP0002078_abnormal_glucose_homeostasis | 0.83943518 |
| 64 | MP0002452_abnormal_antigen_presenting | 0.83335316 |
| 65 | MP0009763_increased_sensitivity_to | 0.83278371 |
| 66 | MP0006036_abnormal_mitochondrial_physio | 0.80165633 |
| 67 | MP0008469_abnormal_protein_level | 0.78778311 |
| 68 | MP0002136_abnormal_kidney_physiology | 0.78624927 |
| 69 | MP0001533_abnormal_skeleton_physiology | 0.74601255 |
| 70 | MP0004947_skin_inflammation | 0.73952176 |
| 71 | MP0005376_homeostasis/metabolism_phenot | 0.73769005 |
| 72 | MP0002723_abnormal_immune_serum | 0.73609862 |
| 73 | MP0010368_abnormal_lymphatic_system | 0.73147368 |
| 74 | MP0003718_maternal_effect | 0.73062671 |
| 75 | MP0005164_abnormal_response_to | 0.73042292 |
| 76 | MP0009765_abnormal_xenobiotic_induced | 0.72786448 |
| 77 | MP0001545_abnormal_hematopoietic_system | 0.71962196 |
| 78 | MP0005397_hematopoietic_system_phenotyp | 0.71962196 |
| 79 | MP0010234_abnormal_vibrissa_follicle | 0.71594791 |
| 80 | MP0005220_abnormal_exocrine_pancreas | 0.71054511 |
| 81 | MP0002971_abnormal_brown_adipose | 0.70314729 |
| 82 | MP0005310_abnormal_salivary_gland | 0.69291469 |
| 83 | MP0005448_abnormal_energy_balance | 0.67964183 |
| 84 | MP0002295_abnormal_pulmonary_circulatio | 0.65671997 |
| 85 | MP0005334_abnormal_fat_pad | 0.64798748 |
| 86 | MP0003941_abnormal_skin_development | 0.64587431 |
| 87 | MP0005535_abnormal_body_temperature | 0.64579836 |
| 88 | MP0003329_amyloid_beta_deposits | 0.64560759 |
| 89 | MP0009333_abnormal_splenocyte_physiolog | 0.64322538 |
| 90 | MP0001765_abnormal_ion_homeostasis | 0.63257927 |
| 91 | MP0005395_other_phenotype | 0.62985767 |
| 92 | MP0005266_abnormal_metabolism | 0.62111130 |
| 93 | MP0001661_extended_life_span | 0.61864908 |
| 94 | MP0005671_abnormal_response_to | 0.60133654 |
| 95 | MP0009053_abnormal_anal_canal | 0.59109359 |
| 96 | MP0005670_abnormal_white_adipose | 0.58354818 |
| 97 | MP0002822_catalepsy | 0.58120319 |
| 98 | MP0003172_abnormal_lysosome_physiology | 0.57005190 |
| 99 | MP0001915_intracranial_hemorrhage | 0.55399643 |
| 100 | MP0000538_abnormal_urinary_bladder | 0.55223634 |
| 101 | MP0010352_gastrointestinal_tract_polyps | 0.55014935 |
| 102 | MP0002405_respiratory_system_inflammati | 0.53028622 |
| 103 | MP0000343_altered_response_to | 0.52914631 |
| 104 | MP0008438_abnormal_cutaneous_collagen | 0.52163765 |
| 105 | MP0003448_altered_tumor_morphology | 0.51883145 |
| 106 | MP0004782_abnormal_surfactant_physiolog | 0.51581691 |
| 107 | MP0002928_abnormal_bile_duct | 0.51046210 |
| 108 | MP0000639_abnormal_adrenal_gland | 0.50935075 |
| 109 | MP0003638_abnormal_response/metabolism_ | 0.50631398 |
| 110 | MP0003953_abnormal_hormone_level | 0.49118326 |
| 111 | MP0003300_gastrointestinal_ulcer | 0.48862461 |
| 112 | MP0004130_abnormal_muscle_cell | 0.48165093 |
| 113 | MP0003690_abnormal_glial_cell | 0.46390270 |
| 114 | MP0005464_abnormal_platelet_physiology | 0.45318325 |
| 115 | MP0006035_abnormal_mitochondrial_morpho | 0.44258064 |
| 116 | MP0000230_abnormal_systemic_arterial | 0.43611650 |
| 117 | MP0005666_abnormal_adipose_tissue | 0.40435461 |
| 118 | MP0002168_other_aberrant_phenotype | 0.39561526 |
| 119 | MP0002796_impaired_skin_barrier | 0.39511710 |
| 120 | MP0008872_abnormal_physiological_respon | 0.39127741 |
| 121 | MP0008873_increased_physiological_sensi | 0.39019656 |
| 122 | MP0009115_abnormal_fat_cell | 0.36312021 |
| 123 | MP0003724_increased_susceptibility_to | 0.35908479 |
| 124 | MP0008874_decreased_physiological_sensi | 0.35773863 |
| 125 | MP0005167_abnormal_blood-brain_barrier | 0.34853849 |
| 126 | MP0005058_abnormal_lysosome_morphology | 0.33936134 |
| 127 | MP0009672_abnormal_birth_weight | 0.33292189 |
| 128 | MP0005166_decreased_susceptibility_to | 0.31336450 |
| 129 | MP0002135_abnormal_kidney_morphology | 0.31328755 |
| 130 | MP0005248_abnormal_Harderian_gland | 0.30710003 |
| 131 | MP0002837_dystrophic_cardiac_calcinosis | 0.30708403 |
| 132 | MP0003075_altered_response_to | 0.30069376 |
| 133 | MP0004147_increased_porphyrin_level | 0.30042845 |
| 134 | MP0000249_abnormal_blood_vessel | 0.28955394 |
| 135 | MP0000579_abnormal_nail_morphology | 0.28601464 |
| 136 | MP0001944_abnormal_pancreas_morphology | 0.27810403 |
| 137 | MP0000462_abnormal_digestive_system | 0.27122457 |
| 138 | MP0003436_decreased_susceptibility_to | 0.26703400 |
| 139 | MP0001881_abnormal_mammary_gland | 0.26606338 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 6.84642238 |
| 2 | Intrahepatic cholestasis (HP:0001406) | 6.64598886 |
| 3 | Hypobetalipoproteinemia (HP:0003563) | 6.64198823 |
| 4 | Deep venous thrombosis (HP:0002625) | 6.48498271 |
| 5 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.21719184 |
| 6 | Xanthomatosis (HP:0000991) | 5.98072725 |
| 7 | Prolonged partial thromboplastin time (HP:0003645) | 5.54415159 |
| 8 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 5.14112131 |
| 9 | Hypolipoproteinemia (HP:0010981) | 4.77201457 |
| 10 | Hyperlipoproteinemia (HP:0010980) | 4.73864100 |
| 11 | Hyperglycinuria (HP:0003108) | 4.66897445 |
| 12 | Hyperammonemia (HP:0001987) | 4.54836049 |
| 13 | Abnormality of glycine metabolism (HP:0010895) | 4.36117627 |
| 14 | Abnormality of serine family amino acid metabolism (HP:0010894) | 4.36117627 |
| 15 | Ketosis (HP:0001946) | 4.33892788 |
| 16 | Hyperglycinemia (HP:0002154) | 4.28916616 |
| 17 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 4.26434140 |
| 18 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.26233776 |
| 19 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.19345335 |
| 20 | Joint hemorrhage (HP:0005261) | 4.15561704 |
| 21 | Conjugated hyperbilirubinemia (HP:0002908) | 4.13648600 |
| 22 | Fat malabsorption (HP:0002630) | 4.13017106 |
| 23 | Epidermoid cyst (HP:0200040) | 4.12359233 |
| 24 | Hypoglycemic coma (HP:0001325) | 4.11025022 |
| 25 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.05888861 |
| 26 | Abnormality of the common coagulation pathway (HP:0010990) | 3.98639670 |
| 27 | Complement deficiency (HP:0004431) | 3.85722061 |
| 28 | Hypoalphalipoproteinemia (HP:0003233) | 3.81187388 |
| 29 | Abnormality of methionine metabolism (HP:0010901) | 3.64167655 |
| 30 | Hypercholesterolemia (HP:0003124) | 3.61878327 |
| 31 | Abnormality of glycolipid metabolism (HP:0010969) | 3.56384702 |
| 32 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.56384702 |
| 33 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.56384702 |
| 34 | Ketoacidosis (HP:0001993) | 3.54860659 |
| 35 | Vacuolated lymphocytes (HP:0001922) | 3.45464683 |
| 36 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.45440762 |
| 37 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.44566917 |
| 38 | Abnormality of nucleobase metabolism (HP:0010932) | 3.40484797 |
| 39 | Abnormality of purine metabolism (HP:0004352) | 3.38006814 |
| 40 | Abnormality of the intrinsic pathway (HP:0010989) | 3.35738148 |
| 41 | Hyperbilirubinemia (HP:0002904) | 3.31055759 |
| 42 | Gout (HP:0001997) | 3.27327351 |
| 43 | Acanthocytosis (HP:0001927) | 3.24700613 |
| 44 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.20871842 |
| 45 | Malnutrition (HP:0004395) | 3.09586613 |
| 46 | Delayed CNS myelination (HP:0002188) | 3.05398522 |
| 47 | Nausea (HP:0002018) | 3.04390150 |
| 48 | Metabolic acidosis (HP:0001942) | 3.03345706 |
| 49 | Nephritis (HP:0000123) | 2.90712715 |
| 50 | Abnormality of serum amino acid levels (HP:0003112) | 2.87630827 |
| 51 | Hepatocellular carcinoma (HP:0001402) | 2.81910472 |
| 52 | Vascular calcification (HP:0004934) | 2.77926420 |
| 53 | Hypoglycemic seizures (HP:0002173) | 2.77681543 |
| 54 | Abnormality of complement system (HP:0005339) | 2.74274417 |
| 55 | Abnormality of proline metabolism (HP:0010907) | 2.72928499 |
| 56 | Hydroxyprolinuria (HP:0003080) | 2.72928499 |
| 57 | Steatorrhea (HP:0002570) | 2.69545364 |
| 58 | Dicarboxylic aciduria (HP:0003215) | 2.69538196 |
| 59 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.69538196 |
| 60 | Proximal tubulopathy (HP:0000114) | 2.60812175 |
| 61 | Lethargy (HP:0001254) | 2.60812035 |
| 62 | Generalized aminoaciduria (HP:0002909) | 2.58603320 |
| 63 | Spontaneous abortion (HP:0005268) | 2.55773625 |
| 64 | Skin nodule (HP:0200036) | 2.54271107 |
| 65 | Glycosuria (HP:0003076) | 2.53348585 |
| 66 | Abnormality of urine glucose concentration (HP:0011016) | 2.53348585 |
| 67 | Myocardial infarction (HP:0001658) | 2.52043262 |
| 68 | Alkalosis (HP:0001948) | 2.47730987 |
| 69 | Late onset (HP:0003584) | 2.46988549 |
| 70 | Cardiovascular calcification (HP:0011915) | 2.46412351 |
| 71 | Irritability (HP:0000737) | 2.42571345 |
| 72 | Purpura (HP:0000979) | 2.41521058 |
| 73 | Hyperuricemia (HP:0002149) | 2.38685955 |
| 74 | Increased purine levels (HP:0004368) | 2.38685955 |
| 75 | Reduced antithrombin III activity (HP:0001976) | 2.35216319 |
| 76 | Gingival bleeding (HP:0000225) | 2.32983881 |
| 77 | Hypochromic microcytic anemia (HP:0004840) | 2.32473212 |
| 78 | Poikilocytosis (HP:0004447) | 2.31489480 |
| 79 | Autoimmune hemolytic anemia (HP:0001890) | 2.30172143 |
| 80 | Abnormal gallbladder physiology (HP:0012438) | 2.27927463 |
| 81 | Cholecystitis (HP:0001082) | 2.27927463 |
| 82 | Spastic diplegia (HP:0001264) | 2.27911630 |
| 83 | Abnormal gallbladder morphology (HP:0012437) | 2.27811638 |
| 84 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.27622766 |
| 85 | Pancreatitis (HP:0001733) | 2.23121445 |
| 86 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.21090763 |
| 87 | Cholelithiasis (HP:0001081) | 2.20800412 |
| 88 | Vomiting (HP:0002013) | 2.20266394 |
| 89 | Rickets (HP:0002748) | 2.19909906 |
| 90 | Esophageal varix (HP:0002040) | 2.18605103 |
| 91 | Glomerulonephritis (HP:0000099) | 2.18257816 |
| 92 | Beaking of vertebral bodies (HP:0004568) | 2.17751905 |
| 93 | Enlarged kidneys (HP:0000105) | 2.15576727 |
| 94 | Dysostosis multiplex (HP:0000943) | 2.11922838 |
| 95 | Amyloidosis (HP:0011034) | 2.11665097 |
| 96 | Systemic lupus erythematosus (HP:0002725) | 2.11615243 |
| 97 | Cerebral edema (HP:0002181) | 2.11545918 |
| 98 | Increased serum ferritin (HP:0003281) | 2.11529652 |
| 99 | Elevated alkaline phosphatase (HP:0003155) | 2.11022666 |
| 100 | Sensorimotor neuropathy (HP:0007141) | 2.10799230 |
| 101 | Neonatal onset (HP:0003623) | 2.08480531 |
| 102 | Joint swelling (HP:0001386) | 2.07690381 |
| 103 | Mitral stenosis (HP:0001718) | 2.07440619 |
| 104 | Confusion (HP:0001289) | 2.07430755 |
| 105 | Symptomatic seizures (HP:0011145) | 2.05610822 |
| 106 | Thrombophlebitis (HP:0004418) | 2.02808725 |
| 107 | Abnormality of iron homeostasis (HP:0011031) | 2.02056349 |
| 108 | Abnormality of alkaline phosphatase activity (HP:0004379) | 2.01208386 |
| 109 | Abnormality of vitamin metabolism (HP:0100508) | 2.00822809 |
| 110 | Recurrent abscess formation (HP:0002722) | 1.99296651 |
| 111 | Brushfield spots (HP:0001088) | 1.98394868 |
| 112 | Nephrolithiasis (HP:0000787) | 1.98163494 |
| 113 | Autoimmune thrombocytopenia (HP:0001973) | 1.96414289 |
| 114 | Abnormality of macrophages (HP:0004311) | 1.95242184 |
| 115 | Abnormal biliary tract physiology (HP:0012439) | 1.94694401 |
| 116 | Bile duct proliferation (HP:0001408) | 1.94694401 |
| 117 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.93948124 |
| 118 | Petechiae (HP:0000967) | 1.93597575 |
| 119 | Conjunctival telangiectasia (HP:0000524) | 1.91299575 |
| 120 | Menorrhagia (HP:0000132) | 1.90701447 |
| 121 | Disinhibition (HP:0000734) | 1.90642963 |
| 122 | Pulmonary embolism (HP:0002204) | 1.89380752 |
| 123 | Hypophosphatemic rickets (HP:0004912) | 1.88498578 |
| 124 | Abnormal cartilage morphology (HP:0002763) | 1.88046914 |
| 125 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.87130126 |
| 126 | Cerebral palsy (HP:0100021) | 1.86319131 |
| 127 | Abnormality of the gallbladder (HP:0005264) | 1.85642631 |
| 128 | Hyperglycemia (HP:0003074) | 1.85615999 |
| 129 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.85602833 |
| 130 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.85602833 |
| 131 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.85602833 |
| 132 | Ileus (HP:0002595) | 1.85056781 |
| 133 | Hemorrhage of the eye (HP:0011885) | 1.84265508 |
| 134 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.84057803 |
| 135 | Mucopolysacchariduria (HP:0008155) | 1.84057803 |
| 136 | Hypophosphatemia (HP:0002148) | 1.82715501 |
| 137 | Gangrene (HP:0100758) | 1.77991938 |
| 138 | Recurrent bacterial skin infections (HP:0005406) | 1.74609732 |
| 139 | Increased cerebral lipofuscin (HP:0011813) | 1.71375330 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 6.16892771 |
| 2 | FGFR4 | 3.93258387 |
| 3 | ERN1 | 3.84515739 |
| 4 | TRIM28 | 3.81870074 |
| 5 | SIK1 | 3.71695283 |
| 6 | FRK | 3.45688062 |
| 7 | TAOK3 | 3.33672803 |
| 8 | ACVR1B | 3.19766386 |
| 9 | INSRR | 2.99680352 |
| 10 | MST1R | 2.92800137 |
| 11 | ERBB4 | 2.42066280 |
| 12 | GRK7 | 2.41779613 |
| 13 | SIK3 | 2.41246262 |
| 14 | LATS1 | 2.32315219 |
| 15 | BCR | 2.17551141 |
| 16 | EIF2AK3 | 2.06302141 |
| 17 | WNK4 | 2.00039501 |
| 18 | PKN2 | 1.91622316 |
| 19 | PDK2 | 1.81786042 |
| 20 | MAP2K4 | 1.80123789 |
| 21 | WNK3 | 1.71089717 |
| 22 | PTK6 | 1.70732030 |
| 23 | MYLK | 1.66027600 |
| 24 | PIK3CG | 1.62911118 |
| 25 | MAP4K1 | 1.61084571 |
| 26 | STK24 | 1.60525808 |
| 27 | MAPK11 | 1.58944046 |
| 28 | GRK6 | 1.58736652 |
| 29 | DDR2 | 1.56079054 |
| 30 | FLT3 | 1.55815567 |
| 31 | STK38L | 1.53317413 |
| 32 | PRKAA2 | 1.46748382 |
| 33 | TYK2 | 1.44479318 |
| 34 | STK16 | 1.42997752 |
| 35 | BLK | 1.41704314 |
| 36 | BUB1 | 1.41200801 |
| 37 | TRIB3 | 1.39494372 |
| 38 | MUSK | 1.37174885 |
| 39 | OXSR1 | 1.36392400 |
| 40 | BMPR2 | 1.32992953 |
| 41 | NME2 | 1.29858611 |
| 42 | IKBKE | 1.27572599 |
| 43 | ABL2 | 1.23413701 |
| 44 | MAP3K12 | 1.20974027 |
| 45 | DAPK2 | 1.17689084 |
| 46 | RIPK1 | 1.17487281 |
| 47 | TEC | 1.17025689 |
| 48 | MET | 1.15687597 |
| 49 | STK10 | 1.15480656 |
| 50 | MAP3K10 | 1.13244754 |
| 51 | NEK9 | 1.12640978 |
| 52 | FGFR2 | 1.12467635 |
| 53 | MAP3K7 | 1.10889719 |
| 54 | BRSK2 | 1.03968045 |
| 55 | PINK1 | 1.01352737 |
| 56 | JAK2 | 0.99411128 |
| 57 | MAPKAPK3 | 0.99208349 |
| 58 | PRKAA1 | 0.97687568 |
| 59 | PLK4 | 0.95050256 |
| 60 | KDR | 0.91557514 |
| 61 | PTK2 | 0.89558104 |
| 62 | JAK3 | 0.88870635 |
| 63 | KIT | 0.88154467 |
| 64 | EPHB1 | 0.87966978 |
| 65 | SGK3 | 0.86765598 |
| 66 | MAP3K3 | 0.86537159 |
| 67 | ERBB2 | 0.84758618 |
| 68 | MELK | 0.83552810 |
| 69 | CSF1R | 0.82362093 |
| 70 | TAOK2 | 0.81668114 |
| 71 | PRPF4B | 0.81494233 |
| 72 | IKBKB | 0.81223894 |
| 73 | WEE1 | 0.80401196 |
| 74 | PRKCZ | 0.80133783 |
| 75 | MAP3K6 | 0.79171509 |
| 76 | AKT3 | 0.78525090 |
| 77 | MAP3K11 | 0.77572075 |
| 78 | GSK3A | 0.77570618 |
| 79 | TAF1 | 0.77262511 |
| 80 | TNK2 | 0.77102690 |
| 81 | MATK | 0.77050607 |
| 82 | TBK1 | 0.75930334 |
| 83 | MOS | 0.75851738 |
| 84 | EIF2AK2 | 0.75325189 |
| 85 | PRKG2 | 0.72707600 |
| 86 | IRAK4 | 0.72635913 |
| 87 | MARK3 | 0.72452744 |
| 88 | PRKACG | 0.72124081 |
| 89 | SGK223 | 0.71879876 |
| 90 | SGK494 | 0.71879876 |
| 91 | JAK1 | 0.71859988 |
| 92 | SGK2 | 0.71061115 |
| 93 | KSR2 | 0.71003614 |
| 94 | MAP2K3 | 0.70587378 |
| 95 | MAP3K2 | 0.68838579 |
| 96 | DYRK1B | 0.67407190 |
| 97 | CDK6 | 0.65766172 |
| 98 | MAP2K2 | 0.64639253 |
| 99 | TIE1 | 0.63847355 |
| 100 | TRPM7 | 0.63810734 |
| 101 | NLK | 0.63800492 |
| 102 | LRRK2 | 0.63653616 |
| 103 | MAPK4 | 0.63194343 |
| 104 | CAMK1D | 0.62835437 |
| 105 | CSK | 0.62140279 |
| 106 | MAPK15 | 0.60814341 |
| 107 | TXK | 0.60466390 |
| 108 | PDK3 | 0.60196935 |
| 109 | PDK4 | 0.60196935 |
| 110 | MAPKAPK2 | 0.60113641 |
| 111 | PDPK1 | 0.59741037 |
| 112 | ZAP70 | 0.58758715 |
| 113 | CDC42BPA | 0.57960872 |
| 114 | MAP2K6 | 0.57573672 |
| 115 | MAP3K14 | 0.57321220 |
| 116 | LYN | 0.56767273 |
| 117 | TESK1 | 0.56704479 |
| 118 | MAP2K1 | 0.56565063 |
| 119 | LMTK2 | 0.56396874 |
| 120 | TESK2 | 0.54122850 |
| 121 | EPHA3 | 0.54085291 |
| 122 | NUAK1 | 0.51304549 |
| 123 | SMG1 | 0.51087878 |
| 124 | IRAK3 | 0.50844459 |
| 125 | MAP3K1 | 0.49566058 |
| 126 | FGR | 0.49090287 |
| 127 | GRK1 | 0.47832911 |
| 128 | YES1 | 0.47796524 |
| 129 | MAP3K13 | 0.47631059 |
| 130 | FGFR3 | 0.47622074 |
| 131 | PAK4 | 0.46473004 |
| 132 | CAMK2G | 0.46206431 |
| 133 | STK3 | 0.44484150 |
| 134 | KSR1 | 0.43725912 |
| 135 | PAK3 | 0.42841157 |
| 136 | PBK | 0.42745870 |
| 137 | BTK | 0.42477504 |
| 138 | DYRK3 | 0.42196422 |
| 139 | VRK2 | 0.41966964 |
| 140 | CSNK1G1 | 0.41202720 |
| 141 | CDK9 | 0.41094563 |
| 142 | RET | 0.40223728 |
| 143 | MAPK12 | 0.39960605 |
| 144 | ABL1 | 0.39789062 |
| 145 | PRKCQ | 0.39717682 |
| 146 | ITK | 0.39423569 |
| 147 | TGFBR2 | 0.38278757 |
| 148 | PIK3CA | 0.37748851 |
| 149 | EPHA2 | 0.35211033 |
| 150 | TAOK1 | 0.35094544 |
| 151 | IGF1R | 0.34957554 |
| 152 | MAP3K5 | 0.34580768 |
| 153 | FER | 0.33877989 |
| 154 | PRKCD | 0.33085923 |
| 155 | LATS2 | 0.32995861 |
| 156 | NEK1 | 0.32691430 |
| 157 | STK39 | 0.32207269 |
| 158 | EPHB2 | 0.32036255 |
| 159 | PDK1 | 0.31774755 |
| 160 | MTOR | 0.30138201 |
| 161 | PRKCA | 0.29167913 |
| 162 | MST4 | 0.28334740 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.79516131 |
| 2 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.57603422 |
| 3 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.35141950 |
| 4 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.96575033 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.87658375 |
| 6 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.70083501 |
| 7 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.68831613 |
| 8 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.58737227 |
| 9 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.55109640 |
| 10 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.44877892 |
| 11 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.40225187 |
| 12 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.31892388 |
| 13 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.28275659 |
| 14 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.24512819 |
| 15 | Peroxisome_Homo sapiens_hsa04146 | 2.04974323 |
| 16 | * Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.04624237 |
| 17 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.03784458 |
| 18 | Histidine metabolism_Homo sapiens_hsa00340 | 2.02816579 |
| 19 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.92046545 |
| 20 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.86520396 |
| 21 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.85979173 |
| 22 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.85784468 |
| 23 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.79033932 |
| 24 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.77623475 |
| 25 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.75657431 |
| 26 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.73256769 |
| 27 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.71906409 |
| 28 | Bile secretion_Homo sapiens_hsa04976 | 1.68576303 |
| 29 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.68182001 |
| 30 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.66698458 |
| 31 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.60810011 |
| 32 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.59869725 |
| 33 | Retinol metabolism_Homo sapiens_hsa00830 | 1.58686142 |
| 34 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.57490432 |
| 35 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.53653044 |
| 36 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.52473482 |
| 37 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.48727379 |
| 38 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.48364916 |
| 39 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.43088592 |
| 40 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.41192376 |
| 41 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.40443414 |
| 42 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.39776323 |
| 43 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.31673303 |
| 44 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.24913335 |
| 45 | ABC transporters_Homo sapiens_hsa02010 | 1.23539475 |
| 46 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.21883833 |
| 47 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.21868065 |
| 48 | Carbon metabolism_Homo sapiens_hsa01200 | 1.19312641 |
| 49 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.18267601 |
| 50 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.17981711 |
| 51 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.13392686 |
| 52 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.13177426 |
| 53 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.11581847 |
| 54 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.02295731 |
| 55 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.95363319 |
| 56 | Lysine degradation_Homo sapiens_hsa00310 | 0.91816786 |
| 57 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.88701114 |
| 58 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.87337287 |
| 59 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.85377980 |
| 60 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.84513289 |
| 61 | Allograft rejection_Homo sapiens_hsa05330 | 0.83817214 |
| 62 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.83128712 |
| 63 | Asthma_Homo sapiens_hsa05310 | 0.80592721 |
| 64 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.77205920 |
| 65 | Sulfur relay system_Homo sapiens_hsa04122 | 0.76880004 |
| 66 | Lysosome_Homo sapiens_hsa04142 | 0.68788100 |
| 67 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.66622661 |
| 68 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.66126129 |
| 69 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.66097401 |
| 70 | Pertussis_Homo sapiens_hsa05133 | 0.65476338 |
| 71 | Galactose metabolism_Homo sapiens_hsa00052 | 0.58560318 |
| 72 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.58413776 |
| 73 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.58010732 |
| 74 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.55657016 |
| 75 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.55394091 |
| 76 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.53586282 |
| 77 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.46938365 |
| 78 | Metabolic pathways_Homo sapiens_hsa01100 | 0.46859232 |
| 79 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.45960820 |
| 80 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.40807456 |
| 81 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.40465122 |
| 82 | Mineral absorption_Homo sapiens_hsa04978 | 0.33209420 |
| 83 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.32248846 |
| 84 | Leishmaniasis_Homo sapiens_hsa05140 | 0.31888651 |
| 85 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.31169733 |
| 86 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.27705786 |
| 87 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.26757859 |
| 88 | Insulin resistance_Homo sapiens_hsa04931 | 0.24671422 |
| 89 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.23116521 |
| 90 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.22576619 |
| 91 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.20438871 |
| 92 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.18631920 |
| 93 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.17753496 |
| 94 | Malaria_Homo sapiens_hsa05144 | 0.16663854 |
| 95 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.15745551 |
| 96 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.13843038 |
| 97 | Tuberculosis_Homo sapiens_hsa05152 | 0.12979459 |
| 98 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.12702370 |
| 99 | Influenza A_Homo sapiens_hsa05164 | 0.12196304 |
| 100 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.10884757 |
| 101 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.09283623 |
| 102 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.08399293 |
| 103 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.07272743 |
| 104 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.06931474 |
| 105 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.05879205 |
| 106 | Legionellosis_Homo sapiens_hsa05134 | 0.05119701 |
| 107 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.03814984 |
| 108 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.03785111 |
| 109 | Prion diseases_Homo sapiens_hsa05020 | 0.01061233 |
| 110 | Circadian rhythm_Homo sapiens_hsa04710 | -0.2285167 |
| 111 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.2116297 |
| 112 | Other glycan degradation_Homo sapiens_hsa00511 | -0.2028047 |
| 113 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.1889124 |
| 114 | Bladder cancer_Homo sapiens_hsa05219 | -0.1829914 |
| 115 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.1688222 |
| 116 | Type II diabetes mellitus_Homo sapiens_hsa04930 | -0.1647889 |
| 117 | Ether lipid metabolism_Homo sapiens_hsa00565 | -0.1613742 |
| 118 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.1610660 |
| 119 | Hepatitis C_Homo sapiens_hsa05160 | -0.1593282 |
| 120 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.1532958 |
| 121 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.1072298 |
| 122 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.1051076 |
| 123 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.0723875 |
| 124 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.0330366 |
| 125 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0022733 |

